Literature DB >> 7398983

[Local therapy of androgenetic alopecia with 17 alpha-estradiol. A controlled, randomized double-blind study (author's transl)].

C E Orfanos, L Vogels.   

Abstract

In a controlled, randomized double-blind study, 51 patients with androgenetic alopecia and increased hair loss (telogen rate greater than 20%) were treated by local application of hair lotions with and without 17 alpha-estradiol (0.025%) for a period of at least 6 months. Before and after therapy trichograms were taken and evaluated under standardized conditions. In 63% of the treated patients a reduction of the amount of telogen hairs appeared, whereas in the control group the same reduction was found in only 37% of the cases. Similarly, in the treated group only 11% of the patients worsened, in contrast to 50% of the control group who showed an increased telogen rate (greater than 10%). The amount of growing anagen hairs and of seborrhea did not change significantly in both groups. Side effects were not seen. These findings indicate that hair lotions containing 17 alpha-estradiol may have a therapeutic value in reducing androgenetic hair loss, if applied topically for a long period of time, similar to 17 beta-estradiol. However, no regrowth of new hair was found.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7398983

Source DB:  PubMed          Journal:  Dermatologica        ISSN: 0011-9075


  6 in total

1.  Male pattern baldness and its management: an update.

Authors:  P C Cotterill; W P Unger
Journal:  Can Fam Physician       Date:  1987-11       Impact factor: 3.275

Review 2.  Interventions for female pattern hair loss.

Authors:  Esther J van Zuuren; Zbys Fedorowicz; Jan Schoones
Journal:  Cochrane Database Syst Rev       Date:  2016-05-26

3.  The Efficacy and Safety of 17α-Estradiol (Ell-Cranell® alpha 0.025%) Solution on Female Pattern Hair Loss: Single Center, Open-Label, Non-Comparative, Phase IV Study.

Authors:  Jae-Hong Kim; Sung Yul Lee; Hae-Jin Lee; Na-Young Yoon; Won-Soo Lee
Journal:  Ann Dermatol       Date:  2012-07-25       Impact factor: 1.444

4.  Strategies and Challenges in Clinical Trials Targeting Human Aging.

Authors:  John C Newman; Sofiya Milman; Shahrukh K Hashmi; Steve N Austad; James L Kirkland; Jeffrey B Halter; Nir Barzilai
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2016-08-16       Impact factor: 6.053

5.  Health benefits attributed to 17α-estradiol, a lifespan-extending compound, are mediated through estrogen receptor α.

Authors:  Shivani N Mann; Niran Hadad; Molly Nelson Holte; Alicia R Rothman; Roshini Sathiaseelan; Samim Ali Mondal; Martin-Paul Agbaga; Archana Unnikrishnan; Malayannan Subramaniam; John Hawse; Derek M Huffman; Willard M Freeman; Michael B Stout
Journal:  Elife       Date:  2020-12-08       Impact factor: 8.140

6.  Therapeutic Efficacy of a Combination Therapy of Topical 17α-Estradiol and Topical Minoxidil on Female Pattern Hair Loss: A Noncomparative, Retrospective Evaluation.

Authors:  Sung Jay Choe; Solam Lee; Jaewoong Choi; Won-Soo Lee
Journal:  Ann Dermatol       Date:  2017-05-11       Impact factor: 1.444

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.